Lipocine Inc. — Director's Dealing 2018

Jun 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2018-06-27

Reporting Person: Higuchi John W. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-27	Stock Option (Right to Buy)	$1.33	A	20000	Acquired	2028-06-27	Common Stock (20000)	Direct

Footnotes

F1: 100% vesting one year from date of grant